BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 82477)

  • 1. Common human melanoma membrane antigens detected by mixed hemadsorption microassay with serum from a patient undergoing immunotherapy with autologous tumor cells.
    Liao SK; Leong SP; Sutherland CM; Dent PB; Kwong PC; Krementz ET
    Cancer Res; 1978 Dec; 38(12):4395-400. PubMed ID: 82477
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunofluorescent detection of common melanoma membrane antigens by sera of melanoma patients immunized against autologous or allogeneic cultured melanoma cells.
    Leong SP; Sutherland CM; Krementz ET
    Cancer Res; 1977 Nov; 37(11):4035-42. PubMed ID: 332343
    [No Abstract]   [Full Text] [Related]  

  • 3. [Serological analysis of melanoma patients receiving autologous melanoma cell vaccines].
    Watanabe T
    Gan To Kagaku Ryoho; 1983 Feb; 10(2 Pt):261-72. PubMed ID: 6881976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Development in the immunotherapy of malignant melanoma].
    Tritsch H
    Hautarzt; 1976 Jan; 27(1):1-7. PubMed ID: 767300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immunological aspects of melanoma].
    Sjögren H
    Lakartidningen; 1976 Feb; 73(7):528-30. PubMed ID: 1250045
    [No Abstract]   [Full Text] [Related]  

  • 6. Antibody-induced movement of common melanoma membrane antigens on the surface of unfixed human melanoma cells.
    Leong SP; Cooperband SR; Deckers PJ; Sutherland CM; Cesare JF; Krementz ET
    Cancer Res; 1979 Jun; 39(6 Pt 1):2125-31. PubMed ID: 376115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progress of immunotherapy in the treatment of malignant melanoma.
    Ariyan S
    Yale J Biol Med; 1975 Nov; 48(5):423-9. PubMed ID: 1108459
    [No Abstract]   [Full Text] [Related]  

  • 8. Spectrum of melanoma antigens on cultured human malignant melanoma cells as detected by monkey antibodies.
    Liao SK; Kwong PC; Thompson JC; Dent PB
    Cancer Res; 1979 Jan; 39(1):183-92. PubMed ID: 83908
    [No Abstract]   [Full Text] [Related]  

  • 9. Intralesional BCG, intravenous immune lymphocytes, and immunization with neuraminidase-treated tumor cells to manage melanoma; A clinical assessment.
    Seigler HF; Shingleton WW; Pickrell KL
    Plast Reconstr Surg; 1975 Mar; 55(3):294-8. PubMed ID: 1118487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Demonstration of two distinct antigens in spent tissue culture medium of a human malignant melanoma cell line.
    Gupta RK; Irie RF; Chee DO; Kern DH; Morton DL
    J Natl Cancer Inst; 1979 Aug; 63(2):347-56. PubMed ID: 88538
    [No Abstract]   [Full Text] [Related]  

  • 11. [Vaccine therapy of malignant melanoma. II. Serological evaluation of the immune responses to the injection using allogeneic melanoma cell vaccine].
    Takeyama H; Watanabe T; Livingston PO
    Gan To Kagaku Ryoho; 1983 Jul; 10(7):1624-33. PubMed ID: 6870307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Augmentation of autologous antibody to human melanoma following acid dissociation and ultrafiltration of serum.
    Kirkwood JM; Vlock DR
    Cancer Res; 1984 Sep; 44(9):4177-82. PubMed ID: 6744327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunotherapy in malignant melanomaa.
    Homes EC; Morton DL; Eilber FR; Golub SE; Sulit HL
    Natl Cancer Inst Monogr; 1976 Nov; 44():85-6. PubMed ID: 799763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterogeneity of melanoma-associated antigens detected by sera from patients receiving adjuvant allogeneic tumor vaccine immunotherapy.
    Dent PB; McCulloch PB; Liao SK; Stone BR; Singal DP
    Clin Immunol Immunopathol; 1982 May; 23(2):379-91. PubMed ID: 6980756
    [No Abstract]   [Full Text] [Related]  

  • 15. Cancer immunotherapy.
    Richman SP; Gutterman JU; Hersh EM
    Can Med Assoc J; 1979 Feb; 120(3):322-4, 329. PubMed ID: 371776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunotherapy of malignant melanoma.
    Terry WD
    N Engl J Med; 1980 Nov; 303(20):1174-5. PubMed ID: 6999351
    [No Abstract]   [Full Text] [Related]  

  • 17. [Basis for a specific-active immunotherapy in malignant melanoma].
    Mutzner PA; Stuhlmiller GM; Seigler HF; Stumpf WE; Sar M
    Schweiz Med Wochenschr; 1981 Sep; 111(36):1322-5. PubMed ID: 7302537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific immunoreactivity of hybridoma-secreted monoclonal anti-melanoma antibodies to cultured cells and freshly derived human cells.
    Herlyn M; Clark WH; Mastrangelo MJ; Guerry DP; Elder DE; LaRossa D; Hamilton R; Bondi E; Tuthill R; Steplewski Z; Koprowski H
    Cancer Res; 1980 Oct; 40(10):3602-9. PubMed ID: 6159966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of preexisting tumor immunity on Bacillus Calmette-Guérin immunotherapy of guinea pigs with both regional and disseminated tumor.
    Jessup JM; Riggs CW; Hanna MG
    Cancer Res; 1977 Aug; 37(8 Pt 1):2565-73. PubMed ID: 872084
    [No Abstract]   [Full Text] [Related]  

  • 20. Isolation and immunochemical characterization of antibodies from the sera of cancer patients which are reactive against human melanoma cell membranes by affinity chromatography.
    Gupta RK; Silver HK; Reisfeld RA; Morton DL
    Cancer Res; 1979 May; 39(5):1683-95. PubMed ID: 427806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.